Clinical Characteristics and Treatment Response of Peripheral Neuropathy in the Presence of Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Experience at a Single Tertiary Center
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic small-vessel vasculitis accompanied by asthma, eosinophilia, and eosinophilic inflammation of various tissues including the peripheral nerves. This study investigated the clinical course and long-term outcomes of peripheral neuropathy in patients with EGPA. Methods Seventy-one patients with physician-diagnosed EGPA were identified at Samsung Medical Center between January 1995 and April 2014. Sixty-one of these patients were followed-up for more than 1 year and received corticosteroid therapy with or without intravenous cyclophosphamide pulse therapy for 6 to 18 months. Medical records of the 61 patients including demographic data, clinical features, laboratory and pathological findings, treatments, and outcomes were reviewed. Results Peripheral neuropathy as a manifestation of EGPA was present in 46 (75%) of the 61 patients. The mean follow-up duration of the patients with neuropathy was 6.4 years (range 1.2–18.8 years). The scores on the neurological functional disability scale before and after the combination treatment with corticosteroid and cyclophosphamide were 2.43±0.86 and 0.54±0.95 (mean±SD; p<0.001), respectively. The peripheral neuropathy relapsed in one patient. Conclusions The long-term clinical outcome of peripheral neuropathy in patients with EGPA receiving initial corticosteroid and cyclophosphamide combination therapy was favorable with a very low relapse rate.
Abstract
Background and Purpose Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic small-vessel vasculitis accompanied by asthma, eosinophilia, and eosinophilic inflammation of various tissues including the peripheral nerves. This study investigated the clinical course and long-term outcomes of peripheral neuropathy in patients with EGPA. Methods Seventy-one patients with physician-diagnosed EGPA were identified at Samsung Medical Center between January 1995 and April 2014. Sixty-one of these patients were followed-up for more than 1 year and received corticosteroid therapy with or without intravenous cyclophosphamide pulse therapy for 6 to 18 months. Medical records of the 61 patients including demographic data, clinical features, laboratory and pathological findings, treatments, and outcomes were reviewed. Results Peripheral neuropathy as a manifestation of EGPA was present in 46 (75%) of the 61 patients. The mean follow-up duration of the patients with neuropathy was 6.4 years (range 1.2–18.8 years). The scores on the neurological functional disability scale before and after the combination treatment with corticosteroid and cyclophosphamide were 2.43±0.86 and 0.54±0.95 (mean±SD; p<0.001), respectively. The peripheral neuropathy relapsed in one patient. Conclusions The long-term clinical outcome of peripheral neuropathy in patients with EGPA receiving initial corticosteroid and cyclophosphamide combination therapy was favorable with a very low relapse rate.
참고문헌 (17)
- Hattori N, "Mortality and morbidity in peripheral neuropathy associated Churg-Strauss syndrome and microscopic polyangiitis", J Rheumatol, 29, pp.1408~1414 (2002)
- Wolf J, "Neurologic compli-cations of Churg-Strauss syndrome--a prospective monocentric study", Eur J Neurol, 17, pp.582~588 (2010)
- Cattaneo L, "Peripheral neuropathy in Wegener’s granulomatosis, Churg-Strauss syndrome and microscopic polyangiitis", J Neurol Neurosurg Psychiatry, 78, pp.1119~1123 (2007)
- Oka N, "Two subtypes of Churg-Strauss syndrome with neuropathy: the roles of eosinophils and ANCA", Mod Rheumatol, 21, pp.290~295 (2011)
- Yamasaki A, "Repressed ileal artery aneurysms in Churg-Strauss syndrome following combination treatment with glucocorticoid and cyclophosphamide", Rheumatol Int, 29, pp.335~337 (2009)
- Hattori N, "Clinicopathological features of Churg-Strauss syndromeassociated neuropathy", Brain, 122(Pt 3), pp.427~439 (1999)
- Samson M, "Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials", J Autoimmun, 43, pp.60~69 (2013)
- Ribi C, "Treatment of Churg-Strauss syndrome without poor-prognosis factors:a multicenter, prospective, randomized, open-label study of seventy-two patients", Arthritis Rheum, 58, pp.586~594 (2008)
- Moiseev S, "Five Factor Score in patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss; EGPA): to use or not to use?", Ann Rheum Dis, 73, pp.e12~ (2014)
- Comarmond C, "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383patients enrolled in the French Vasculitis Study Group cohort", Arthritis Rheum, 65, pp.270~281 (2013)
- Gayraud M, "Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides", Br J Rheumatol, 36, pp.1290~1297 (1997)
- Cohen P, "Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients", Arthritis Rheum, 57, pp.686~693 (2007)
- Sehgal M, "Neurologic manifestations of Churg-Strauss syndrome", Mayo Clin Proc, 70, pp.337~341 (1995)
- de Groot K, "Standardized neurologic evaluations of 128 patients with Wegener granulomatosis", Arch Neurol, 58, pp.1215~1221 (2001)
- Pagnoux C, "Churg-Strauss syndrome", Curr Opin Rheumatol, 19, pp.25~32 (2007)
- Sokolowska BM, "ANCA-positive and ANCA-negative phenotypes of eosinophilic granulomatosis with polyangiitis (EGPA): outcome and long-term follow-up of 50 patients from a single Polish center", Clin Exp Rheumatol, 32(3 Suppl 82), pp.S41~S47 (2014)
- 김미영, "Clinical features and prognostic factors of Churg-Strauss syndrome", The Korean Journal of Internal Medicine, 29(1), pp.85~95 (2014), 대한내과학회[DOI]